Roche Diagnostics
Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon. Their broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover the early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring.
Top Stages
1 past transactions
Constitution Medical Investors
Acquisition in 2013
Constitution Medical Investors (CMI), headquartered in Boston, Massachusetts, USA, is a healthcare-focused business engaged in developing innovative hematology testing systems. These systems aim to accelerate accurate diagnosis of blood-related diseases, ultimately enhancing patient care. Established with backing from Warburg Pincus and CMI's management team, the company specializes in identifying and acquiring healthcare platform technologies and companies, leveraging its expertise in product development, regulatory affairs, clinical trials, and commercialization.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.